# EDGAR Filing Document

**Accession Number:** 0000080424
**File Stem:** 0000080424-23-000008
**Filing Date:** 2023-1
**Character Count:** 42980
**Document Hash:** 86dd08ac1e750fab22986b772952455e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000080424-23-000008.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0000080424-23-000008

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20230119

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PROCTER & GAMBLE Co
- **CENTRAL INDEX KEY:** 0000080424
- **STANDARD INDUSTRIAL CLASSIFICATION:** SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
- **IRS NUMBER:** 310411980
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-00434
- **FILM NUMBER:** 23535907

**BUSINESS ADDRESS:**
- **STREET 1:** ONE PROCTER & GAMBLE PLAZA
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45202
- **BUSINESS PHONE:** 5139831100

**MAIL ADDRESS:**
- **STREET 1:** ONE PROCTER & GAMBLE PLAZA
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROCTER & GAMBLE CO
- **DATE OF NAME CHANGE:** 19920703

?xml version="1.0" ? pg-20230119

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

---

| | |
|:---|:---|
| **FORM** | **8-K** |

---

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934

---

| | |
|:---|:---|
| **Date of Report (Date of earliest event reported)** | **January 19, 2023** |

---

![pg-20230119_g1.jpg](pg-20230119_g1.jpg)

**THE PROCTER & GAMBLE COMPANY**

***(Exact name of registrant as specified in its charter)***

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Ohio** | **OH** | **1-434** | | **31-0411980** |
| ***(State of Incorporation)*** | | ***(Commission File Number)*** | | ***(I.R.S. Employer Identification Number)*** |
| **One Procter & Gamble Plaza** | **,** | **Cincinnati** | **OH** |  |
| **One Procter & Gamble Plaza, Cincinnati, Ohio** | **One Procter & Gamble Plaza, Cincinnati, Ohio** | **One Procter & Gamble Plaza, Cincinnati, Ohio** | **45202** | **45202** |
| ***(Address of principal executive offices)*** | ***(Address of principal executive offices)*** | ***(Address of principal executive offices)*** | ***(Zip Code)*** | ***(Zip Code)*** |

---

**(513) 983-1100** 

***(Registrant's telephone number, including area code)***

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

---

| | |
|:---|:---|
| False | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| False | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| False | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| False | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, without Par Value | PG | NYSE |
| 1.125% Notes due 2023 | PG23A | NYSE |
| 0.500% Notes due 2024 | PG24A | NYSE |
| 0.625% Notes due 2024 | PG24B | NYSE |
| 1.375% Notes due 2025 | PG25 | NYSE |
| 0.110% Notes due 2026 | PG26D | NYSE |
| 4.875% EUR notes due May 2027 | PG27A | NYSE |
| 1.200% Notes due 2028 | PG28 | NYSE |
| 1.250% Notes due 2029 | PG29B | NYSE |
| 1.800% Notes due 2029 | PG29A | NYSE |
| 6.250% GBP notes due January 2030 | PG30 | NYSE |
| 0.350% Notes due 2030 | PG30C | NYSE |
| 0.230% Notes due 2031 | PG31A | NYSE |
| 5.250% GBP notes due January 2033 | PG33 | NYSE |
| 1.875% Notes due 2038 | PG38 | NYSE |
| 0.900% Notes due 2041 | PG41 | NYSE |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻False

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

---

| | |
|:---|:---|
| **ITEM 2.02** | **RESULTS OF OPERATIONS AND FINANCIAL CONDITION** |
| On January 19, 2023, The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended December 31, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition." | On January 19, 2023, The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended December 31, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition." |

---

---

| | |
|:---|:---|
| **ITEM 9.01** | **FINANCIAL STATEMENTS AND EXHIBITS** |
| **<u>Exhibit Number</u>** | **<u>Description</u>** |
| 99.1 | News Release by The Procter & Gamble Company dated January 19, 2023. |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **THE PROCTER & GAMBLE COMPANY** | **THE PROCTER & GAMBLE COMPANY** |
| By | <u>/s/ SANDRA T. LANE</u> |
| | Sandra T. Lane, Assistant Secretary |
| | 1/19/2023 |

---

**EXHIBIT(S)**

<u>[99.1](fy2223q2ond8-kexhibit991.htm)</u> <u>[News Release by The Procter & Gamble Company dated January 19, 2023](fy2223q2ond8-kexhibit991.htm)</u>.

## Exhibit 99.1

![pglogoa21.jpg](pglogoa21.jpg)

---

| | |
|:---|:---|
| ***News Release*** | **The Procter & Gamble Company** |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One P&G Plaza |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cincinnati, OH 45202 |

---

---

| |
|:---|
| **<u>P&G ANNOUNCES FISCAL YEAR 2023 SECOND QUARTER RESULTS</u>** |
| *<u>Net Sales -1%; Organic Sales +5%;</u>* |
| *<u>Diluted EPS and Core EPS $1.59, each -4%</u>* |
| *<u>RAISES SALES GROWTH OUTLOOK</u>* |
| *<u>MAINTAINS FISCAL YEAR EPS GROWTH & CASH GUIDANCE RANGES</u>* |

---

CINCINNATI, January 19, 2023 - The Procter & Gamble Company (NYSE:PG) reported second quarter fiscal year 2023 net sales of $20.8 billion, a decrease of one percent versus the prior year. Excluding the impacts of foreign exchange and acquisitions and divestitures, organic sales increased five percent. Diluted net earnings per share were $1.59, a decrease of four percent versus prior year EPS.

Operating cash flow was $3.6 billion, and net earnings were $4.0 billion for the quarter. Adjusted free cash flow productivity was 72%, which is calculated as operating cash flow, less capital spending, as a percentage of net earnings. The Company returned $4.2 billion of cash to shareholders via approximately $2.2 billion of dividend payments and $2 billion of common stock repurchases.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **$ billions, except EPS** | **$ billions, except EPS** | | | | | | |
| **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Second Quarter** |
| **GAAP** | **2023** | **2022** | **% Change** | **Non-GAAP\*** | **2023** | **2022** | **% Change** |
| Net Sales | 20.8 | 21.0 | (1)% | Organic Sales | n/a | n/a | 5% |
| Diluted EPS | 1.59 | 1.66 | (4)% | Core EPS | 1.59 | 1.66 | (4)% |

---

\*Please refer to Exhibit 1 - Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures.

"We delivered solid results in the second quarter of fiscal year 2023 in what continues to be a very difficult cost and operating environment," said Jon Moeller, Chairman of the Board, President and Chief Executive Officer. "Progress against our plan fiscal year to date enables us to raise our sales growth outlook for fiscal 2023 and maintain our guidance range for EPS growth despite significant headwinds. We remain committed to our integrated strategies of a focused product portfolio, superiority, productivity, constructive disruption and an agile and accountable organization structure. These strategies have enabled us to build and sustain strong momentum. They remain the right strategies to navigate through the near-term challenges we're facing and continue to deliver balanced growth and value creation."

------

**October - December Quarter Discussion**

Net sales in the second quarter of fiscal year 2023 were $20.8 billion, a one percent decrease versus the prior year. Unfavorable foreign exchange had a six percent impact on net sales. Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased five percent. The organic sales increase was driven by a ten percent increase from higher pricing and a one percent increase from positive product mix, partially offset by a six percent decrease in shipment volumes.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **<u>October - December 2022</u>** | **<u>Volume</u>** | **<u>Foreign Exchange</u>** | **<u>Price</u>** | **<u>Mix</u>** | **<u>Other</u>** <sup>(2)</sup> | **<u>Net Sales</u>** | **<u>Organic Volume</u>** | **<u>Organic Sales</u>** |
| **<u>Net Sales Drivers</u>** <sup>(1)</sup> | **<u>Volume</u>** | **<u>Foreign Exchange</u>** | **<u>Price</u>** | **<u>Mix</u>** | **<u>Other</u>** <sup>(2)</sup> | **<u>Net Sales</u>** | **<u>Organic Volume</u>** | **<u>Organic Sales</u>** |
| Beauty | (4)% | (8)% | 9% | (2)% | 2% | (3)% | (4)% | 3% |
| Grooming | (8)% | (9)% | 11% | (3)% | —% | (9)% | (8)% | —% |
| Health Care | (1)% | (6)% | 5% | 4% | —% | 2% | (1)% | 8% |
| Fabric & Home Care | (7)% | (7)% | 13% | 2% | —% | 1% | (7)% | 8% |
| Baby, Feminine & Family Care | (6)% | (5)% | 8% | 2% | —% | (1)% | (6)% | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total P&G** | **(6)%** | **(6)%** | **10%** | **1%** | **—%** | **(1)%** | **(6)%** | **5%** |

---

<sup>(1)</sup> Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

<sup>(2)</sup> Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

• Beauty segment organic sales increased three percent versus year ago. Skin and Personal Care organic sales increased low single digits due to innovation-driven volume growth and higher pricing, partially offset by negative mix from COVID-related declines in SK-II. Hair Care organic sales increased mid-single digits driven by increased pricing, partially offset by volume declines due to market contraction.

• Grooming segment organic sales were unchanged versus year ago as higher pricing was fully offset by volume decline and negative mix, due to market contraction and retailer inventory reductions of appliances.

• Health Care segment organic sales increased eight percent versus year ago. Oral Care organic sales increased low single digits due to increased pricing and favorable geographic mix, partially offset by volume declines due to portfolio reduction in Russia and COVID-related disruptions in Greater China. Personal Health Care organic sales increased high-teens due to increased pricing, favorable mix and volume growth driven by a strong cough, cold and flu season.

• Fabric and Home Care segment organic sales increased eight percent versus year ago. Fabric Care organic sales increased high single digits due to increased pricing, partially offset by volume declines due to market contraction and increased pricing, primarily in Europe. Home Care organic sales

------

increased high single digits due to increased pricing, partially offset by volume declines versus a high base period of increased consumption of cleaning products.

• Baby, Feminine and Family Care segment organic sales increased four percent versus year ago. Baby Care organic sales increased low single digits due to increased pricing, partially offset by volume declines from market contraction. Feminine Care organic sales increased high single digits driven by increased pricing and positive geographic mix, partially offset by volume declines in emerging markets. Family Care organic sales increased low single digits due to increased pricing, partially offset by lower volumes due to market contraction and market share softness.

Diluted net earnings per share decreased by four percent to $1.59, driven by a decline in net sales and a decrease in operating margin partially offset by a lower effective tax rate and a reduction in shares outstanding. Currency-neutral EPS were up five percent versus the prior year EPS.

Gross margin for the quarter decreased 160 basis points versus year ago, 100 basis points on a currency-neutral basis. The decline was driven by 380 basis points of increased commodity and input material costs, 130 basis points of negative product mix and 140 basis points of capacity start-up costs and other impacts. These were partially offset by benefits of 470 basis points from increased pricing and 80 basis points from gross productivity savings.

Selling, general and administrative expense (SG&A) as a percentage of sales increased 10 basis points versus year ago and decreased 30 basis points on a currency-neutral basis. The decrease was driven by 130 basis points of leverage due to organic sales growth and 30 basis points of productivity savings, partially offset by 130 basis points of inflation, capability investments and other impacts.

Operating margin for the quarter decreased 170 basis points versus the prior year, 70 basis points on a currency-neutral basis. Operating margin included gross productivity savings of 110 basis points.

------

**Fiscal Year 2023 Guidance**

P&G raised its guidance for fiscal 2023 all-in sales to a range of down one percent to in-line versus the prior fiscal year from a prior range of down three percent to down one percent. The Company also raised its outlook for organic sales growth to a range of four to five percent versus the prior fiscal year from a prior growth range of three to five percent. Foreign exchange is now expected to be a five percentage point headwind to all-in sales growth for the fiscal year.

P&G maintained its outlook for fiscal 2023 diluted net earnings per share growth in the range of in-line to up four percent versus fiscal 2022 EPS of $5.81. The Company added that given continued significant cost headwinds from commodity and materials costs and foreign exchange impacts, it continues to expect EPS results to be towards the lower end of the fiscal year guidance range.

P&G said its current fiscal 2023 outlook includes headwinds of approximately $1.2 billion after-tax due to unfavorable foreign exchange rates, $2.3 billion due to higher commodity and materials costs, and $200 million from higher freight costs. Combined, these items are a $3.7 billion after-tax headwind, or approximately $1.50 per share, to fiscal 2023 earnings versus fiscal 2022, or a headwind of approximately 26 points to EPS growth. The $3.7 billion headwind is a modest sequential improvement versus guidance provided in October, due to both commodities and foreign exchange.

The Company is unable to reconcile its forward-looking non-GAAP cash flow measure and tax rate measures without unreasonable efforts because the Company cannot predict the timing and amounts of discrete cash items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.

P&G now expects a core effective tax rate of approximately 20% in fiscal 2023.

Capital spending is estimated to be approximately 5% of fiscal 2023 net sales.

P&G continues to expect adjusted free cash flow productivity of 90% and expects to pay around $9 billion in dividends and to repurchase $6 billion to $8 billion of common shares in fiscal 2023.

------

**Forward-Looking Statements**

Certain statements in this release, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war (including the Russia Ukraine War) or terrorism or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by

successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, labor and employment, antitrust, privacy and data protection, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company's overall business strategy and financial objectives, without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (17) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns (including COVID-19); (18) the ability to manage the uncertainties, sanctions and economic effects from the war between Russia and Ukraine; and (19) the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

------

**About Procter & Gamble**

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

\# \# \#

**<u>P&G Media Contacts</u>:**

Erica Noble, 513.271.1793

Jennifer Corso, 513.983.2570

**<u>P&G Investor Relations Contact</u>:**

John Chevalier, 513.983.9974

*Category: PG-IR*

------

---

| | | | |
|:---|:---|:---|:---|
| **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES** |
| **(Amounts in Millions Except Per Share Amounts)** | **(Amounts in Millions Except Per Share Amounts)** | **(Amounts in Millions Except Per Share Amounts)** | **(Amounts in Millions Except Per Share Amounts)** |
| **Consolidated Earnings Information** | **Consolidated Earnings Information** | **Consolidated Earnings Information** | **Consolidated Earnings Information** |
| | **Three Months Ended December 31** | **Three Months Ended December 31** | **Three Months Ended December 31** |
|  | **2022** | **2021** | **% Chg** |
| **NET SALES** | 20773 | 20953 | (1)% |
| &nbsp;&nbsp;&nbsp;Cost of products sold | 10897 | 10664 | 2% |
| **GROSS PROFIT** | 9876 | 10289 | (4)% |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expense | 5091 | 5121 | (1)% |
| **OPERATING INCOME** | 4785 | 5168 | (7)% |
| &nbsp;&nbsp;&nbsp;Interest expense | (171) | (106) | 61% |
| &nbsp;&nbsp;&nbsp;Interest income | 66 | 10 | 560% |
| &nbsp;&nbsp;&nbsp;Other non-operating income, net | 155 | 167 | (7)% |
| **EARNINGS BEFORE INCOME TAXES** | 4835 | 5239 | (8)% |
| &nbsp;&nbsp;&nbsp;Income taxes | 876 | 997 | (12)% |
| **NET EARNINGS** | 3959 | 4242 | (7)% |
| &nbsp;&nbsp;&nbsp;Less: Net earnings attributable to noncontrolling interests | 26 | 19 | 37% |
| **NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE** | 3933 | 4223 | (7)% |
| **EFFECTIVE TAX RATE** | 18.1% | 19.0% |  |
| **NET EARNINGS PER SHARE** <sup>(1)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 1.63 | 1.72 | (5)% |
| &nbsp;&nbsp;&nbsp;Diluted | 1.59 | 1.66 | (4)% |
| **DIVIDENDS PER COMMON SHARE** | 0.9133 | 0.8698 |  |
| DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | 2481.2 | 2544.2 |  |
| **COMPARISONS AS A % OF NET SALES** |  |  | **Basis Pt Chg** |
| &nbsp;&nbsp;&nbsp;Gross profit | 47.5% | 49.1% | (160) |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expense | 24.5% | 24.4% | 10 |
| &nbsp;&nbsp;&nbsp;Operating income | 23.0% | 24.7% | (170) |
| &nbsp;&nbsp;&nbsp;Earnings before income taxes | 23.3% | 25.0% | (170) |
| &nbsp;&nbsp;&nbsp;Net earnings | 19.1% | 20.2% | (110) |
| &nbsp;&nbsp;&nbsp;Net earnings attributable to Procter & Gamble | 18.9% | 20.2% | (130) |

---

<sup>(1)</sup> Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions)<br>**Consolidated Earnings Information** |
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| | **Net Sales** | **% Change Versus Year Ago** | **Earnings/(Loss) Before Income Taxes** | **% Change Versus Year Ago** | **Net Earnings/(Loss)** | **% Change Versus Year Ago** |
| Beauty | $3807 | (3)% | $1145 | (3)% | $911 | (4)% |
| Grooming | 1643 | (9)% | 496 | (14)% | 404 | (15)% |
| Health Care | 3051 | 2% | 887 | (2)% | 686 | (2)% |
| Fabric & Home Care | 7032 | 1% | 1538 | 5% | 1171 | 3% |
| Baby, Feminine & Family Care | 5065 | (1)% | 1112 | (6)% | 848 | (7)% |
| Corporate | 175 | N/A | (343) | N/A | (61) | N/A |
| **Total Company** | **$20773** | **(1)%** | **$4835** | **(8)%** | **$3959** | **(7)%** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| **<u>Net Sales Drivers</u>** <sup>(1)</sup> | **Volume** | **Organic Volume** | **Foreign Exchange** | **Price** | **Mix** | **Other** <sup>(2)</sup> | **Net Sales** |
| Beauty | (4)% | (4)% | (8)% | 9% | (2)% | 2% | (3)% |
| Grooming | (8)% | (8)% | (9)% | 11% | (3)% | —% | (9)% |
| Health Care | (1)% | (1)% | (6)% | 5% | 4% | —% | 2% |
| Fabric & Home Care | (7)% | (7)% | (7)% | 13% | 2% | —% | 1% |
| Baby, Feminine & Family Care | (6)% | (6)% | (5)% | 8% | 2% | —% | (1)% |
| **Total Company** | **(6)%** | **(6)%** | **(6)%** | **10%** | **1%** | **—%** | **(1)%** |

---

<sup>(1)</sup> Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

------

---

| | | |
|:---|:---|:---|
| **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Consolidated Statements of Cash Flows** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Consolidated Statements of Cash Flows** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Consolidated Statements of Cash Flows** |
| | **Six Months Ended December 31** | **Six Months Ended December 31** |
| **<u>Amounts in millions</u>** | **2022** | **2021** |
| **CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD** | $7214 | $10288 |
| **OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings | 7922 | 8368 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 1316 | 1395 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 250 | 268 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (398) | (101) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets | (3) | (82) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (654) | (644) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (655) | (840) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued and other liabilities | 177 | 1431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating assets and liabilities | (535) | (84) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 224 | 53 |
| **TOTAL OPERATING ACTIVITIES** | 7644 | 9764 |
| **INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (1598) | (1717) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from asset sales | 8 | 97 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisitions, net of cash acquired | (76) | (349) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activity | 344 | 3 |
| **TOTAL INVESTING ACTIVITIES** | (1322) | (1966) |
| **FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends to shareholders | (4486) | (4353) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions to short-term debt with original maturities of more than three months | 10447 | 6747 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reductions in short-term debt with original maturities of more than three months | (3260) | (1730) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net reductions to other short-term debt | (1759) | (1124) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions to long-term debt |  | 2136 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reductions in long-term debt | (1877) | (1673) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock purchases | (6002) | (7504) |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of stock options and other | 437 | 1215 |
| **TOTAL FINANCING ACTIVITIES** | (6500) | (6286) |
| **EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH** | (182) | (256) |
| **CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH** | (360) | 1256 |
| **CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD** | $6854 | $11544 |

---

------

---

| | | |
|:---|:---|:---|
| **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Condensed Consolidated Balance Sheets** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Condensed Consolidated Balance Sheets** | **THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES**<br>(Amounts in Millions Except Per Share Amounts)<br>**Condensed Consolidated Balance Sheets** |
| | **December 31, 2022** | **June 30, 2022** |
| Cash and cash equivalents | $6854 | $7214 |
| Accounts receivable | 5767 | 5143 |
| Inventories | 7541 | 6924 |
| Prepaid expenses and other current assets | 1704 | 2372 |
| **TOTAL CURRENT ASSETS** | 21866 | 21653 |
| Property, plant and equipment, net | 21167 | 21195 |
| Goodwill | 39951 | 39700 |
| Trademarks and other intangible assets, net | 23594 | 23679 |
| Other noncurrent assets | 11137 | 10981 |
| **TOTAL ASSETS** | $117715 | $117208 |
| Accounts payable | $14153 | $14882 |
| Accrued and other liabilities | 10293 | 9554 |
| Debt due within one year | 14300 | 8645 |
| **TOTAL CURRENT LIABILITIES** | 38746 | 33081 |
| Long-term debt | 20582 | 22848 |
| Deferred income taxes | 6462 | 6809 |
| Other noncurrent liabilities | 7200 | 7616 |
| **TOTAL LIABILITIES** | 72990 | 70354 |
| **TOTAL SHAREHOLDERS' EQUITY** | 44725 | 46854 |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | $117715 | $117208 |

---

------

**The Procter & Gamble Company**

**Exhibit 1: Non-GAAP Measures**

The following provides definitions of the non-GAAP measures used in Procter & Gamble's January 19, 2023 earnings release and the reconciliation to the most closely related GAAP measures. Management believes that these non-GAAP measures provide useful perspective on underlying business trends and provide a supplemental measure of period-to-period financial results. Disclosing these non-GAAP financial measures allows investors and management to view our operating results excluding the impact of items that are not reflective of the underlying operating performance. Management uses these non-GAAP measures in making operating decisions, allocating financial resources and for business strategy purposes. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the Company's reported results prepared in accordance with GAAP. Our non-GAAP financial measures do not represent a comprehensive basis of accounting. Therefore, our non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results.

<u>Organic sales growth</u>: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing achievement of management goals for at-risk compensation.

<u>Currency-neutral operating margin:</u> Currency-neutral operating margin is a measure of the Company's operating margin excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company's operating efficiency over time.

<u>Currency-neutral gross margin</u>: Currency-neutral gross margin is a measure of the Company's gross margin excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company's operating efficiency over time.

------

<u>Currency-neutral selling, general and administrative (SG&A) expense as a percentage of net sales</u>: Currency-neutral SG&A expense as a percentage of net sales is a measure of the Company's selling, general and administrative expenses excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company's operating efficiency over time.

<u>Core EPS:</u> Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share adjusted as indicated. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used when evaluating senior management in determining their at-risk compensation. For the period covered by this release, there are no reconciling items for Core EPS.

<u>Currency-neutral EPS</u>: Currency-neutral EPS is a measure of the Company's EPS excluding the incremental current year impact of foreign exchange. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time.

<u>Adjusted free cash flow</u>: Adjusted free cash flow is defined as operating cash flow less capital spending. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.

<u>Adjusted free cash flow productivity</u>: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings. Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G's ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation.

------

---

| | | |
|:---|:---|:---|
| THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES<br>(Amounts in Millions Except Per Share Amounts)<br>Reconciliation of Non-GAAP Measures | THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES<br>(Amounts in Millions Except Per Share Amounts)<br>Reconciliation of Non-GAAP Measures | THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES<br>(Amounts in Millions Except Per Share Amounts)<br>Reconciliation of Non-GAAP Measures |
|  | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2021** |
|  | **AS REPORTED (GAAP)** | **AS REPORTED (GAAP)** |
| **COST OF PRODUCTS SOLD** | $**10897** | $10664 |
| **GROSS PROFIT** | **9876** | 10289 |
| **GROSS MARGIN** | **47.5%** | 49.1% |
| **CURRENCY IMPACT TO GROSS MARGIN** | **0.6%** |  |
| **CURRENCY-NEUTRAL GROSS MARGIN** | **48.1%** |  |
| **SELLING, GENERAL AND ADMINISTRATIVE EXPENSE** | **5091** | 5121 |
| **SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES** | **24.5%** | 24.4% |
| **CURRENCY IMPACT TO SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES** | **(0.4)%** |  |
| **CURRENCY-NEUTRAL SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES** | **24.1%** |  |
| **OPERATING INCOME** | **4785** | 5168 |
| **OPERATING MARGIN** | **23.0%** | 24.7% |
| **CURRENCY IMPACT TO OPERATING MARGIN** | **1.0%** |  |
| **CURRENCY-NEUTRAL OPERATING MARGIN** | **24.0%** |  |
| **NET EARNINGS ATTRIBUTABLE TO P&G** | **3933** | 4223 |
| **DILUTED NET EARNINGS PER COMMON SHARE** <sup>(1)</sup> | $**1.59** | $1.66 |
| **CURRENCY IMPACT TO EARNINGS** | $**0.16** |  |
| **CURRENCY-NEUTRAL CORE EPS** | $**1.75** |  |
| **DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING** | **2481.2** | 2544.2 |
| **COMMON SHARES OUTSTANDING - December 31, 2022** | **2359.1** |  |

---

<sup>(1)</sup> Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

---

| | | |
|:---|:---|:---|
| **CHANGE IN CURRENT YEAR REPORTED (GAAP) AND NON-GAAP MEASURES VERSUS PRIOR YEAR REPORTED (GAAP) MEASURES** | **CHANGE IN CURRENT YEAR REPORTED (GAAP) AND NON-GAAP MEASURES VERSUS PRIOR YEAR REPORTED (GAAP) MEASURES** | **CHANGE IN CURRENT YEAR REPORTED (GAAP) AND NON-GAAP MEASURES VERSUS PRIOR YEAR REPORTED (GAAP) MEASURES** |
| &nbsp;&nbsp;&nbsp;&nbsp;GROSS MARGIN | (160) | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;CURRENCY-NEUTRAL GROSS MARGIN | (100) | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;SELLING GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES | 10 | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;CURRENCY-NEUTRAL SELLING GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES | (30) | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;OPERATING MARGIN | (170) | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;CURRENCY-NEUTRAL OPERATING MARGIN | (70) | BPS |
| &nbsp;&nbsp;&nbsp;&nbsp;EPS | (4)% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;CURRENCY-NEUTRAL EPS | 5% |  |

---

------

<u>Organic sales growth</u>:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>October - December 2022</u>** | **<u>Net Sales Growth</u>** | **<u>Foreign Exchange Impact</u>** | **<u>Acquisition & Divestiture Impact/Other</u>** <sup>(1)</sup> | **<u>Organic Sales Growth</u>** |
| Beauty | (3)% | 8% | (2)% | 3% |
| Grooming | (9)% | 9% | —% | —% |
| Health Care | 2% | 6% | —% | 8% |
| Fabric & Home Care | 1% | 7% | —% | 8% |
| Baby, Feminine & Family Care | (1)% | 5% | —% | 4% |
| &nbsp;&nbsp;&nbsp;**Total P&G** | **(1)%** | **6%** | **—%** | **5%** |

---

<sup>(1)</sup> Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.

---

| | | | |
|:---|:---|:---|:---|
| **<u>Total P&G</u>** | **<u>Net Sales Growth</u>** | **<u>Combined Foreign Exchange & Acquisition/Divestiture Impact/Other</u>** <sup>(1)</sup> | **<u>Organic Sales Growth</u>** |
| FY 2023 (Estimate) | (1)% to 0% | +5% | +4% to +5% |

---

<sup>(1)</sup> Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.

<u>Adjusted free cash flow (dollar amounts in millions)</u>:

---

| | | |
|:---|:---|:---|
| **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| **<u>Operating Cash Flow</u>** | **<u>Capital Spending</u>** | **<u>Adjusted Free Cash Flow</u>** |
| $3574 | $(708) | $2866 |

---

<u>Adjusted free cash flow productivity (dollar amounts in millions)</u>:

---

| | | |
|:---|:---|:---|
| **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| **<u>Adjusted Free Cash Flow</u>** | **<u>Net Earnings</u>** | **<u>Adjusted Free Cash Flow Productivity</u>** |
| $2866 | $3959 | 72% |

---

<br>